Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for PAHC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 778.20M
March 31, 2026 778.02M
December 31, 2025 764.21M
September 30, 2025 776.08M
June 30, 2025 752.42M
March 31, 2025 761.03M
December 31, 2024 781.44M
September 30, 2024 503.99M
June 30, 2024 518.00M
March 31, 2024 515.88M
December 31, 2023 506.09M
September 30, 2023 511.89M
June 30, 2023 503.91M
March 31, 2023 511.50M
December 31, 2022 505.99M
September 30, 2022 497.44M
June 30, 2022 464.43M
March 31, 2022 449.25M
December 31, 2021 428.14M
September 30, 2021 432.41M
June 30, 2021 420.09M
March 31, 2021 407.23M
December 31, 2020 403.89M
September 30, 2020 414.78M
June 30, 2020 404.28M
Date Value
March 31, 2020 383.40M
December 31, 2019 390.52M
September 30, 2019 410.67M
June 30, 2019 326.18M
March 31, 2019 329.23M
December 31, 2018 324.28M
September 30, 2018 324.33M
June 30, 2018 312.38M
March 31, 2018 309.38M
December 31, 2017 316.37M
September 30, 2017 331.85M
June 30, 2017 313.14M
March 31, 2017 309.46M
December 31, 2016 328.53M
September 30, 2016 342.60M
June 30, 2016 352.71M
March 31, 2016 366.42M
December 31, 2015 305.12M
September 30, 2015 306.33M
June 30, 2015 289.52M
March 31, 2015 287.22M
December 31, 2014 287.94M
September 30, 2014 288.66M
June 30, 2014 289.39M
March 31, 2014 374.47M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 9.238B
Merck & Co., Inc. 51.08B
ANI Pharmaceuticals, Inc. 610.49M
Corcept Therapeutics, Inc. 7.504M
Veru, Inc. 1.908M